Skip to content
GLP-1 Savers
Menu
Ranked #250 · Watch List

VyrarX review

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Est. first month

From $179/mo (starting dose, compounded)

Save ~87% vs brand-name
Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a starting rate, not a price that is guaranteed at every dose. Confirm the current terms on the provider's own site before you commit.
Semaglutide
From $179/mo (starting dose, compounded)
Tirzepatide
From $329/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

VyrarX scored on our six published factors. See the methodology.

Lowest Real Price76/100
No Teaser-Rate Bait64/100
Nationwide Availability45/100
Both Molecules92/100
Easy Cancellation58/100
Reputation73/100

Why it's a deal

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

Read the fine print

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

The bottom line

Best for: Shoppers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states. VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Ranked #250 of 395 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to VyrarX, out of 394 others we track.

Shopping VyrarX against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs VyrarX, and every program that undercuts or outscores it is ranked on the VyrarX alternatives board.

More programs we track (24)

364 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from VyrarX's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on VyrarX's site. Not medical advice; see our disclosure.

← Back to all deals